Mohammed Ali, Boehringer Ingelheim Pharmaceuticals, Inc.

Mohammed Ali Mohammed (Mo) Ali, is the global head for digital development, Global Clinical Operations. He is responsible for the operational execution of the digital development strategy within medicine for Boehringer Ingelheim. He is passionate about digital health and is an evangelist for the advocacy of digital solutions within the patient care and drug development paradigm. His mission is help create alongside his industry peers a closed loop system of digital data driven drug development where the voice of the customer – the patient, the caretaker and the HCP takes center stage in ensuring the best point of care solutions are available for every part of the disease management lifecycle. Previously to joining Boehringer Ingelheim, he has held positions with increasing responsibilities within J&J, Novartis, Roche and Fresenius Healthcare. Mr. Ali has a background in pharmacology and lives with his family in NJ.

Sessions

3:50 PM - 4:10 PM

Optimizing Clinical Trials Using AI

AI and related technologies hold the potential to solve many key clinical trial challenges. Change will not come quickly but the potential results are worth taking the first step in the journey. This session will cover what expectations are realistic in optimizing clinical trials in the near term and in the future as AI continues to be adopted across the industry.
  • Current practices and what can be supplemented by technology?
  • Competencies and capabilities needed in the future.
  • Novel models for clinical trials including robotic process automation.
  • Mohammed Ali

    Mohammed Ali Global Head Digital Trials- Global Clinical Operations Boehringer Ingelheim Pharmaceuticals, Inc.


Download Latest Agenda